199 related articles for article (PubMed ID: 27068427)
1. P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
Burkhard FZ; Parween S; Udhane SS; Flück CE; Pandey AV
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):38-50. PubMed ID: 27068427
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of human P450 oxidoreductase.
Pandey AV; Sproll P
Front Pharmacol; 2014; 5():103. PubMed ID: 24847272
[TBL] [Abstract][Full Text] [Related]
3. In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.
Nurhafizuddin M; Azizi A; Ming LC; Shafqat N
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889519
[TBL] [Abstract][Full Text] [Related]
4. Impact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase.
Flück CE; Pandey AV
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):64-70. PubMed ID: 27032764
[TBL] [Abstract][Full Text] [Related]
5. Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.
Flück CE; Nicolo C; Pandey AV
Fundam Clin Pharmacol; 2007 Aug; 21(4):399-410. PubMed ID: 17635179
[TBL] [Abstract][Full Text] [Related]
6. NADPH P450 oxidoreductase: structure, function, and pathology of diseases.
Pandey AV; Flück CE
Pharmacol Ther; 2013 May; 138(2):229-54. PubMed ID: 23353702
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 oxidoreductase deficiency: rare congenital disorder leading to skeletal malformations and steroidogenic defects.
Fukami M; Ogata T
Pediatr Int; 2014 Dec; 56(6):805-808. PubMed ID: 25294558
[TBL] [Abstract][Full Text] [Related]
8. Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis.
Huang N; Pandey AV; Agrawal V; Reardon W; Lapunzina PD; Mowat D; Jabs EW; Van Vliet G; Sack J; Flück CE; Miller WL
Am J Hum Genet; 2005 May; 76(5):729-49. PubMed ID: 15793702
[TBL] [Abstract][Full Text] [Related]
9. P450 oxidoreductase deficiency: a disorder of steroidogenesis with multiple clinical manifestations.
Miller WL
Sci Signal; 2012 Oct; 5(247):pt11. PubMed ID: 23092891
[TBL] [Abstract][Full Text] [Related]
10. Consequences of POR mutations and polymorphisms.
Miller WL; Agrawal V; Sandee D; Tee MK; Huang N; Choi JH; Morrissey K; Giacomini KM
Mol Cell Endocrinol; 2011 Apr; 336(1-2):174-9. PubMed ID: 21070833
[TBL] [Abstract][Full Text] [Related]
11. P450 oxidoreductase deficiency: a new disorder of steroidogenesis.
Miller WL; Huang N; Pandey AV; Flück CE; Agrawal V
Ann N Y Acad Sci; 2005 Dec; 1061():100-8. PubMed ID: 16467261
[TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
Krone N; Reisch N; Idkowiak J; Dhir V; Ivison HE; Hughes BA; Rose IT; O'Neil DM; Vijzelaar R; Smith MJ; MacDonald F; Cole TR; Adolphs N; Barton JS; Blair EM; Braddock SR; Collins F; Cragun DL; Dattani MT; Day R; Dougan S; Feist M; Gottschalk ME; Gregory JW; Haim M; Harrison R; Olney AH; Hauffa BP; Hindmarsh PC; Hopkin RJ; Jira PE; Kempers M; Kerstens MN; Khalifa MM; Köhler B; Maiter D; Nielsen S; O'Riordan SM; Roth CL; Shane KP; Silink M; Stikkelbroeck NM; Sweeney E; Szarras-Czapnik M; Waterson JR; Williamson L; Hartmann MF; Taylor NF; Wudy SA; Malunowicz EM; Shackleton CH; Arlt W
J Clin Endocrinol Metab; 2012 Feb; 97(2):E257-67. PubMed ID: 22162478
[TBL] [Abstract][Full Text] [Related]
13. Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
Zhang J; Woo KL; Hai Y; Wang S; Lin Y; Huang Y; Peng X; Wu H; Zhang S; Yan L; Li Y
Front Endocrinol (Lausanne); 2022; 13():1020880. PubMed ID: 36518257
[TBL] [Abstract][Full Text] [Related]
14. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.
Jin Y; Chen M; Penning TM; Miller WL
Biochem J; 2015 May; 468(1):25-31. PubMed ID: 25728647
[TBL] [Abstract][Full Text] [Related]
15. Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro.
Sandee D; Morrissey K; Agrawal V; Tam HK; Kramer MA; Tracy TS; Giacomini KM; Miller WL
Pharmacogenet Genomics; 2010 Nov; 20(11):677-86. PubMed ID: 20940534
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review.
Bai Y; Li J; Wang X
J Ovarian Res; 2017 Mar; 10(1):16. PubMed ID: 28288674
[TBL] [Abstract][Full Text] [Related]
17. P450 oxidoreductase deficiency - a new form of congenital adrenal hyperplasia.
Flück CE; Pandey AV; Huang N; Agrawal V; Miller WL
Endocr Dev; 2008; 13():67-81. PubMed ID: 18493134
[TBL] [Abstract][Full Text] [Related]
18. Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients.
Sahakitrungruang T; Huang N; Tee MK; Agrawal V; Russell WE; Crock P; Murphy N; Migeon CJ; Miller WL
J Clin Endocrinol Metab; 2009 Dec; 94(12):4992-5000. PubMed ID: 19837910
[TBL] [Abstract][Full Text] [Related]
19. Exploring Novel Variants of the Cytochrome P450 Reductase Gene (
Rojas Velazquez MN; Therkelsen S; Pandey AV
Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136599
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
